Pathways Case Studies: May 2024 - Insights
Short, interactive case studies from Mayo Clinic physicians, scientists, and allied health staff
Pathways Case Studies: December 2024 - Insights
Short, interactive case studies from Mayo Clinic physicians, scientists, and allied health staff.
Gratitude for your collaboration in 2024 - Insights
Mayo Clinic Laboratories is grateful for your collaboration in 2024.
Dangerous Goods Training Has Moved - Insights
Update your bookmark! Dangerous Goods can now be found at https://news.mayocliniclabs.com/dangerous-goods-training/
Burnout (Part 3): Eudaimonic Well-Being - Insights
Recognizing the significance of eudaimonic well-being in the workplace is essential for employers, as fostering a sense of purpose and fulfillment among employees not only enhances individual satisfaction but also contributes to a positive...
Burnout (Part 1): Identifying Workplace Burnout - Insights
Recognizing the signs of burnout in your employees is key. Taking action early not only boosts their well-being but also prevents serious health and career consequences down the road.
Burnout (Part 2): Burnout Cascade - Insights
Understanding the concept of burnout cascade is paramount for employers, as it not only directly affects the well-being of individual employees but also has the potential to permeate through entire teams, impacting overall productivity,...
Laboratory Identification Number: 29685A Name and Director of Laboratory: MAYO CLINIC LABS-ROCH SUPERIOR DR WILLIAM G. MORICE II 3050 SUPERIOR DRIVE NW ROCHESTER, MN 55901 Owner: MAYO CLINIC ISSUE DATE: August 15, 2024 DATE...
New York State Department of Health Clinical Laboratory Permit Subject to Revocation Permit Not Transferable POST CONSPICUOUSLY is hereby authorized to perform laboratory procedures at the above location in the following categories in...
LinkedIn Login, Sign in | LinkedIn
Login to LinkedIn to keep in touch with people you know, share ideas, and build your career.
LinkedIn Login, Sign in | LinkedIn
Login to LinkedIn to keep in touch with people you know, share ideas, and build your career.
LinkedIn Login, Sign in | LinkedIn
Login to LinkedIn to keep in touch with people you know, share ideas, and build your career.
LinkedIn Login, Sign in | LinkedIn
Login to LinkedIn to keep in touch with people you know, share ideas, and build your career.
LinkedIn Login, Sign in | LinkedIn
Login to LinkedIn to keep in touch with people you know, share ideas, and build your career.
This "Pathways" program provides Anatomic and Clinical Pathology cases that include a history, potential answers, rationale, and relevant references. This case sub-specialty is Renal.
February 2020 - Laboratory Genetics & Genomics - Insights
A 71 yr old female with a history of a central nervous system lymphoma, an allogenic stem cell transplant and graft versus host disease was tested for
Clinical Application of Next-Generation Sequencing (NGS) Testing - Insights
October 8, 2017 | Rochester, Minnesota This symposium is designed for any provider who treats patients with hematologic malignancies (e.g., oncologists, hematologists, and physician assistants), pathologists, hematopathologists,...
Patient Satisfaction in the Nursery [Pediatric Phlebotomy] - Insights
This "Pediatric Phlebotomy" presentation addresses the increase in the number of tests available using a blood spot specimen and concerns about bruising, a team was created to investigate causes of bruising and select the best method for...
Battling Borrelia burgdorferi and mayonii: Know the ABCs of Lyme Disease - Insights
In the United States, Lyme disease is caused by "Borrelia burgdorferi" and "Borrelia mayonii" bacteria, carried primarily by "black-legged" or "deer ticks." To learn more about Lyme disease, the Mayo Clinic Department of Laboratory Medicine...
The Evolution of Phlebotomy - Insights
PACE / State of FLHave you ever wondered how we came from bloodletting and leeches to present day phlebotomy? This presentation is going to walk you through the history and what has led us to some of the advancements in the field of...
Impact of pre-analytical variables on clinical laboratory testing and patient care - Insights
This "Phlebotomy Webinar" presentation highlights the most common pre-analytical variables encountered in the hospital setting that may compromise blood specimen integrity and lead to specimen recollection.
LinkedIn Login, Sign in | LinkedIn
Login to LinkedIn to keep in touch with people you know, share ideas, and build your career.
LinkedIn Login, Sign in | LinkedIn
Login to LinkedIn to keep in touch with people you know, share ideas, and build your career.
LinkedIn Login, Sign in | LinkedIn
Login to LinkedIn to keep in touch with people you know, share ideas, and build your career.
Patients are at the heart of all we do at Mayo Clinic Laboratories. Our laboratory testing can clear the fog of an uncertain diagnosis, point to the next steps in care, and pave the way for better treatment. Our work makes a difference in...
Assay finds genetic cause of low bile flow: Devin Oglesbee, Ph.D. - Insights
Devin Oglesbee, Ph.D., explains how Mayo Clinic Laboratories' cholestasis gene panel identifies mutations that cause low flow of bile from the liver. Test results help guide treatment decisions that can prevent liver damage.
Widening the net to capture elusive pathogens - Insights
Central nervous system infections, such as meningitis and encephalitis, can be devastating for affected patients. While specific treatments are available for some of these infections, it first requires identifying the precise cause of...
FDA-approved test expands options for Alzheimer's disease - Insights
Joshua Bornhorst, Ph.D., describes the new, FDA-approved Alzheimer's disease (AD) test and how it differs from Mayo Clinic Laboratories' existing AD evaluation. The laboratory will offer both tests, to ensure flexibility and options for...
A new comprehensive genetic panel redefines Parkinson's disease diagnosis - Insights
Mayo Clinic Laboratories introduces the Inherited Parkinson’s Disease Gene Panel (Mayo ID: PARDP), a collaborative breakthrough poised to transform Parkinson’s disease diagnosis and treatment. Led by Rodolfo Savica, M.D., Ph.D., and Zhiyv...
Membranous nephropathy assay: PMND1 - Insights
John Lieske, M.D., describes Mayo Clinic Laboratories' new test for primary membranous nephropathy. PMND1 is a diagnostic cascade that provides a cost-effective approach to detecting antigens known to cause membranous nephropathy — a...
IDH assay facilitates timelier leukemia treatment: Rong He, M.D. - Insights
In this test-specific episode of the "Answers From the Lab" podcast, Rong He, M.D., explains how Mayo Clinic Laboratories' IDHQ test improves upon next generation sequencing for assessing AML treatment options.
PIK3CA assay guides treatment of progressing breast cancer - Insights
Katherine Geiersbach, M.D., explains how Mayo Clinic Laboratories' PIK3CA assay informs breast cancer treatment. The assay identifies patients eligible for a certain second-line therapy when initial treatment has failed.
Chromium and Cobalt - Insights
Paul Jannetto, Ph.D., describes Mayo Clinic Laboratories' synovial fluid testing for patients with symptoms of failed hip arthroplasty. The Food and Drug Administration recommends testing for elevated chromium and cobalt, which can indicate...
Autoimmune Myelopathy - Insights
This “Specialty Testing” webinar will describe the clinical, radiologic, and serologic characteristics of autoimmune myelopathies and their mimics.
In this month’s “Virtual Lecture,” James Hernandez, M.D., expresses the importance of safety and why it is integral in processing and phlebotomy.
Legal Updates in Phlebotomy - Insights
This "Phlebotomy" webinar will provide an update of litigation trends affecting phlebotomists.
The Role of CSF in Alzheimer's Disease - Insights
This "Specialty Testing" webinar will discuss Cerebrospinal fluid (CSF), which has been used in research on Alzheimer's disease for decades. Only recently, have platforms been developed to standardize measurements across laboratories.
Phlebotomy COVID-19 Process - Insights
This “Phlebotomy Webinar” will focus on the role of the phlebotomist and the changes adapted to provide service safely to COVID positive patients in different service areas (ED, ICU vs General floors).
Using Phlebotomy Quality Metrics to Improve Patient Care - Insights
This “Phlebotomy Webinar" will discuss the what and why of quality metrics and indicators and how to determine which indicators to monitor.
The following resources can be used as a reminder for staff on the order of putting on and taking off, and reuse of PPE.
Mission not impossible: Overcoming challenging pediatric draws - Insights
This “Phlebotomy Webinar” covers real-life challenging scenarios that arise in the clinical setting. Four unique case studies are presented, and suggestions are discussed on how to help and respond in these situations to support the...
This “phlebotomy webinar” will walk learners through the quality improvement methodology and describe PDSA cycle interventions that were implemented in this unit which successfully reduced the amount of canceled labs due to specimen...
Annual screening for latent tuberculosis in healthcare workers: No longer required - Insights
This "Phlebotomy Webinar" presentation will review the methods available to detect latent infection with Mycobacterium tuberculosis, or latent tuberculosis infection (LTBI), including the classic tuberculin skin test and the more recently...
Whole exome sequencing for hereditary disorders - Insights
Cherisse Marcou, Ph.D., and Marissa Ellingson, M.S., CGC, discuss whole exome sequencing (WES) at Mayo Clinic Laboratories. The comprehensive evaluation uses next-generation sequencing to detect for single nucleotide variants, small...
Linda Hasadsri, M.D., Ph.D., explains carrier screening at Mayo Clinic Laboratories. Using targeted genotyping, our three focused panels evaluate genes associated with cystic fibrosis, spinal muscular atrophy, and hemoglobinopathies, to...
Discontinuation of Herpes Simplex Virus (HSV) IgM Testing - Insights
In this month’s “Hot Topic,” Elitza Theel, Ph.D., will discuss the over utilization of IgM serologic testing for herpes simplex virus and the recommendation by multiple agencies, including the CDC and the Infectious Diseases Society of...
Innovative bile acid malabsorption panel transforms gastrointestinal care - Insights
Mayo Clinic Laboratories has introduced a revolutionary diagnostic test for bile acid malabsorption, a significant contributor to chronic diarrhea. Developed by Dr. Michael Camilleri and Dr. Leslie Donato, this new bile acid malabsorption...
August 2023 - Bone & Soft Tissue - Insights
This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Bone and Soft Tissue Pathology.
Early-Onset IBD: Genetic Testing and Clinical Applications - Insights
Identification of early-onset IBD patients may enable tailored treatment and surveillance plans. With over 50 genes implicated in early-onset IBD, genetic testing should be included in the workup of children under the age of six with IBD....
Testing Options for Patients with Chronic Diarrhea: A Focus on Bile Acid Malabsorption - Insights
This "Specialty Testing" webinar describes a new serum test for bile acid malabsorption. Descriptions illustrate how the test can be used as a screening test and as a tool for therapeutic action.